InnerMedical Co., Ltd. (InnerMed) is proudly celebrating its 8-year anniversary since its establishment in 2015. With a commitment to providing high-quality and innovative diagnostic and treatment solutions in major disease areas, InnerMed has made significant strides in the field of healthcare. The company's focus on digestive and respiratory tract tumors, as well as cardiovascular diseases, has led to groundbreaking advancements in medical technology. Through continuous technological innovation, InnerMed has introduced pioneering products such as the first domestic mini-probe EUS, full HD endoscopy system, internationally leading intravascular dual-mode imaging system, intravascular shock wave, and many more high-quality products that are continuously being launched.

InnerMed places great importance on research and development, establishing multiple technical platforms in ultrasound electronics, optical technology, energy technology, interventional devices, and more, covering over 20 technical sub-directions. The company has built production and research facilities that meet Good Manufacturing Practice (GMP) and ISO 13485 requirements, ensuring a comprehensive and internationally standardized quality assurance system.

Throughout its journey, InnerMed has garnered significant recognition and support. The company has received investments from well-known domestic institutions and multiple government support programs, solidifying its position as a national high-tech enterprise. This acknowledgment highlights InnerMed's dedication to advancing medical technology and contributing to the improvement of patient care in China and beyond.

InnerMed's achievements in the field of medical technology have been particularly impactful in the areas of digestive and respiratory tract tumors as well as cardiovascular diseases. The introduction of the endoscopic ultrasound system has transformed diagnostic capabilities, enabling physicians to visualize and diagnose conditions with unprecedented accuracy. The full HD GI endoscope has enhanced visualization and aided in the early detection and characterization of abnormalities. InnerMed's intravascular dual-mode imaging system has revolutionized intravascular imaging, providing clinicians with advanced tools for precise diagnosis and treatment planning. The intravascular shock wave technology has opened new avenues for non-invasive treatment of cardiovascular diseases. These breakthroughs have significantly contributed to improving patient outcomes and transforming the healthcare landscape.

InnerMed's 8-year anniversary represents a significant milestone in its journey towards transforming healthcare through innovative medical technology solutions. The company's pioneering products and dedication to research and development have revolutionized diagnostic and treatment approaches in the fields of digestive and respiratory tract tumors and cardiovascular diseases. As InnerMed moves forward, it will continue to drive advancements in medical technology, delivering cutting-edge solutions that enhance patient care and improve lives.